PL2897588T3 - Lek wziewny - Google Patents

Lek wziewny

Info

Publication number
PL2897588T3
PL2897588T3 PL14809248T PL14809248T PL2897588T3 PL 2897588 T3 PL2897588 T3 PL 2897588T3 PL 14809248 T PL14809248 T PL 14809248T PL 14809248 T PL14809248 T PL 14809248T PL 2897588 T3 PL2897588 T3 PL 2897588T3
Authority
PL
Poland
Prior art keywords
inhalable medicament
inhalable
medicament
Prior art date
Application number
PL14809248T
Other languages
English (en)
Inventor
Mukui DALVI
Libo Wu
Original Assignee
Teva Branded Pharmaceutical Products R&D, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52014433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2897588(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Branded Pharmaceutical Products R&D, Inc. filed Critical Teva Branded Pharmaceutical Products R&D, Inc.
Publication of PL2897588T3 publication Critical patent/PL2897588T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL14809248T 2013-11-22 2014-11-21 Lek wziewny PL2897588T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361907782P 2013-11-22 2013-11-22
EP14809248.9A EP2897588B1 (en) 2013-11-22 2014-11-21 An inhalable medicament
PCT/US2014/066872 WO2015077594A1 (en) 2013-11-22 2014-11-21 An inhalable medicament

Publications (1)

Publication Number Publication Date
PL2897588T3 true PL2897588T3 (pl) 2019-12-31

Family

ID=52014433

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14809248T PL2897588T3 (pl) 2013-11-22 2014-11-21 Lek wziewny

Country Status (18)

Country Link
US (1) US20160250197A1 (pl)
EP (1) EP2897588B1 (pl)
JP (1) JP2016539126A (pl)
KR (1) KR20160101929A (pl)
CN (1) CN104968328A (pl)
AU (1) AU2014352813A1 (pl)
CA (1) CA2930173A1 (pl)
DK (1) DK2897588T3 (pl)
EA (1) EA201691067A1 (pl)
ES (1) ES2739393T3 (pl)
HK (1) HK1211243A1 (pl)
HU (1) HUE045868T2 (pl)
IL (1) IL245760A0 (pl)
MX (1) MX2016006377A (pl)
PL (1) PL2897588T3 (pl)
TR (1) TR201911194T4 (pl)
WO (1) WO2015077594A1 (pl)
ZA (1) ZA201603464B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1212903A1 (zh) 2013-11-22 2016-06-24 Teva Branded Pharmaceutical Products R & D, Inc. 可吸入藥物
MX386777B (es) * 2016-09-19 2025-03-19 Mexichem Fluor Sa De Cv Composición farmacéutica que comprende un compuesto de tiotropio.
EP3813797A4 (en) * 2018-06-27 2022-03-30 Kindeva Drug Delivery L.P. TIOTROPIUM FORMULATION AND INHALER

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9026191D0 (en) 1990-12-01 1991-01-16 Harris Pharma Ltd Breath actuated dispensing device
GB2264238A (en) 1992-05-29 1993-08-25 Norton Healthcare Ltd Medicament inhalor device
ZA939195B (en) * 1992-12-09 1995-06-08 Boehringer Ingelheim Pharma Stabilized medicinal aerosol solution formulations
RU2126248C1 (ru) * 1992-12-09 1999-02-20 Берингер Ингельхейм Фармасьютикалз, Инк. Жидкая фармацевтическая композиция в форме аэрозоля
US6553988B1 (en) 2000-06-09 2003-04-29 Norton Healthcare, Inc. Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber
AU3297402A (en) * 2001-10-26 2003-10-30 Dey, L.P. An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
JP2003221335A (ja) * 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
CA2510043A1 (en) * 2002-12-16 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing hfc solution formulations
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20070110676A1 (en) * 2005-11-17 2007-05-17 The Procter & Gamble Company Compositions useful for prevention and treatment of common cold and influenza-like symptoms
EP2462140A2 (en) * 2009-08-07 2012-06-13 Generics [UK] Limited Anhydrate of triotropium bromide
WO2012030664A1 (en) * 2010-08-30 2012-03-08 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
PT3470057T (pt) * 2010-09-29 2021-12-03 Pulmatrix Operating Co Inc Pós secos catiónicos compreendendo sais de magnésio
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
HK1212903A1 (zh) * 2013-11-22 2016-06-24 Teva Branded Pharmaceutical Products R & D, Inc. 可吸入藥物

Also Published As

Publication number Publication date
ES2739393T3 (es) 2020-01-30
IL245760A0 (en) 2016-07-31
HK1211243A1 (en) 2016-05-20
CA2930173A1 (en) 2015-05-28
EA201691067A1 (ru) 2016-09-30
DK2897588T3 (da) 2019-08-12
CN104968328A (zh) 2015-10-07
JP2016539126A (ja) 2016-12-15
AU2014352813A1 (en) 2016-05-26
EP2897588B1 (en) 2019-07-17
TR201911194T4 (tr) 2019-08-21
US20160250197A1 (en) 2016-09-01
WO2015077594A1 (en) 2015-05-28
EP2897588A1 (en) 2015-07-29
MX2016006377A (es) 2016-10-28
ZA201603464B (en) 2017-09-27
HUE045868T2 (hu) 2020-01-28
KR20160101929A (ko) 2016-08-26

Similar Documents

Publication Publication Date Title
IL245211A0 (en) an inhaler for the medicine
GB201319150D0 (en) An inhaler
AU351520S (en) Inhaler
SG10201708409VA (en) Medicament device
SG11201507981TA (en) Nasal administration
HUE038547T2 (hu) Inhalátor
AU352076S (en) Inhaler
GB2513553B (en) An Inhaler
ZA201408393B (en) Inhaler device
IL246045B (en) Inhalable drugs
HUE064186T2 (hu) Inhalátor
PT3035886T (pt) Nalador
ZA201508680B (en) Inhaler
ZA201603463B (en) An inhalable medicament
GB201319144D0 (en) An Inhaler
IL245760A0 (en) Inhalation medicine
GB201319152D0 (en) An Inhaler
GB201319145D0 (en) An inhaler
GB201320786D0 (en) Medicament
HK1228315A1 (en) Medicament inhaler
HK1229260A1 (en) Inhalable medicaments
HU4880U (hu) Inhalátor